BR9508419A - Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica - Google Patents

Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica

Info

Publication number
BR9508419A
BR9508419A BR9508419A BR9508419A BR9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A
Authority
BR
Brazil
Prior art keywords
cholinergic
pharmaceutical compositions
binding protein
tnf binding
tnf
Prior art date
Application number
BR9508419A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert Frederick Geoffre Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9508419A publication Critical patent/BR9508419A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9508419A 1994-07-22 1995-07-15 Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica BR9508419A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (1)

Publication Number Publication Date
BR9508419A true BR9508419A (pt) 1997-11-18

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508419A BR9508419A (pt) 1994-07-22 1995-07-15 Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica

Country Status (11)

Country Link
EP (1) EP0772449A1 (no)
JP (1) JPH09508140A (no)
AU (1) AU3111995A (no)
BR (1) BR9508419A (no)
CA (1) CA2195665A1 (no)
CZ (1) CZ283219B6 (no)
FI (1) FI970247A (no)
HU (1) HUT76666A (no)
NO (1) NO970264L (no)
PL (1) PL318501A1 (no)
WO (1) WO1996003141A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033244A2 (en) 1998-11-27 2000-06-08 Synaptics (Uk) Limited Position sensor
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
EP0910413A2 (en) * 1996-05-08 1999-04-28 F. Hoffmann-La Roche Ag TREATMENT OF ASTHMA WITH TNFR-Ig
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
WO1998025967A1 (en) * 1996-12-12 1998-06-18 Genentech, Inc. Hvem polypeptides and uses thereof
MXPA03007563A (es) 2001-02-23 2003-12-11 Immunex Corp Recuperacion incrementada de proteinas activas.
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7674453B2 (en) 2002-02-06 2010-03-09 Ares Trading Sa Tumor necrosis factor combined with interferon in demyelinating diseases
AU2005299716B2 (en) 2004-10-22 2012-09-06 Amgen Inc. Methods for refolding of recombinant antibodies
US11111284B2 (en) 2014-08-21 2021-09-07 The General Hospital Corporation Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
EP0417563B1 (de) * 1989-09-12 2000-07-05 F. Hoffmann-La Roche Ag TNF-bindende Proteine
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
CA2123593C (en) * 1992-09-15 2000-03-14 Craig A. Smith Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
AU682156B2 (en) * 1992-10-15 1997-09-25 Dana-Farber Cancer Institute, Inc. Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-alpha function

Also Published As

Publication number Publication date
PL318501A1 (en) 1997-06-23
JPH09508140A (ja) 1997-08-19
HUT76666A (en) 1997-10-28
CZ283219B6 (cs) 1998-02-18
AU3111995A (en) 1996-02-22
FI970247A0 (fi) 1997-01-21
NO970264D0 (no) 1997-01-21
CA2195665A1 (en) 1996-02-08
FI970247A (fi) 1997-01-21
EP0772449A1 (en) 1997-05-14
NO970264L (no) 1997-03-24
WO1996003141A1 (en) 1996-02-08
CZ19397A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
NO20004345D0 (no) Farmasøytisk sammensetning
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID18352A (id) Komposisi-komposisi farmasi
BR9508419A (pt) Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica
FI955311A0 (fi) Farmaseuttinen koostumuspohja
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
EE03857B1 (et) Ravimkoostised külmkuivatamiseks
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
BR9711315A (pt) Composi-Æo farmac-utica contendo cidos 4-oxobutanÄicos
ID29294A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI962628A0 (it) Composizione farmaceutica
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
NO964309D0 (no) Farmasöytisk sammensetning
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402924D0 (sv) Novel pharmaceutical composition
SE9402437D0 (sv) Pharmaceutical composition
KR960016881A (ko) 제약 조성물

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DO DESPACHO 8.6 NA RPI 1781 DE 22/02/2005.